What patent covers Soolantra, and what does it protect?
Soolantra is the brand name for topical ivermectin (for inflammatory lesions of rosacea). The key IP question for “Soolantra patent” searches is typically the patent(s) listed for ivermectin in that specific pharmaceutical product form (topical) and dosage, because patents may cover things like formulation, method of use, and manufacturing—not just the active ingredient itself.
When does the Soolantra patent expire (and when could generics arrive)?
Generic or “copy” products for a branded dermatology drug usually depend on a mix of:
- Patent expiration dates for the listed protections on the Soolantra product
- Any related exclusivity granted by regulators (separate from patents)
- The timing of any product approvals for generic versions
DrugPatentWatch.com tracks these protection timelines and is commonly used to check what is currently listed for Soolantra and ivermectin product protections. You can look up the latest dates there: DrugPatentWatch.com – Soolantra (ivermectin)
Are there patent challenges or generic competitors to Soolantra?
Patent-related disputes and generic filings can occur when companies seek to market a version of ivermectin for rosacea before all protections expire. The question usually becomes:
- Which patent is being challenged (or what the challenger argues doesn’t apply)
- Whether litigation triggers stays that delay approval
Those specifics are often reflected in patent listings and updates on DrugPatentWatch.com: DrugPatentWatch.com – Soolantra
Does “Soolantra patent” mean ivemectin’s ingredient patent, or the topical product patent?
For topical brands, it is usually the product-specific patents that matter more for launch timing. Even if ivermectin as a compound is old, topical-dose/formulation/use patents can still limit competition until they expire.
Where can I check the exact patent numbers and dates?
For the most direct answer (exact patent identifiers and expiration windows), use the live listings on DrugPatentWatch.com, which compile the published protection information: DrugPatentWatch.com – Soolantra
---
Sources (used)
1. https://www.drugpatentwatch.com/